Biogen (@biogen) / X

Biogen

5,990 posts

Biogen

@biogen

Official global newsroom account for Biogen, a leading biotech company pioneering innovative science since 1978. Community guidelines: bit.ly/1MZocKs

Cambridge, MA

Joined June 2010

Biogen
@biogen
Jul 8, 2020
#Alzheimers disease has a significant impact on patients, care partners and society. Hear from Samantha Budd Haeberlein, SVP, Head of Neurodegeneration Development Unit, on how she is feeling about today’s milestone and why we are so passionate about this #PublicHealth crisis.
Biogen
@biogen
May 24, 2020
#Alzheimers accounts for 60–70% of dementia cases, so what are the possible cognitive & biological markers we can use to make an early diagnosis? Join our #EAN2020 Alzheimer's virtual symposium at 12.15 CEST today to hear more. HCPs can register here ow.ly/ACic50zO7pK
Biogen
@biogen
Dec 23, 2021
Did you know that biologics account for >40% of total medicines spending in the US? The further development and approval of #biosimilars medicines represents a significant opportunity for US patients, healthcare professionals, and the healthcare system.
The Benefits of Biosimilars
From www.biogen.com
Biogen
@biogen
Dec 20, 2021
Increasing the understanding and awareness of #biosimilars may provide an opportunity to drive down costs and expand #patientaccess to #biosimilar therapies. Read the latest white paper from @SamsungBioepis about key strategies to improving robust #biosimilaradoption:
Improving Biosimilar Adoption
From ml.globenewswire.com
Biogen
@biogen
Mar 23, 2015
Committed to community, dedicated to patients & focused on science that truly matters--Visit the NEW #Biogen website
biogen.com
Pioneering innovative science | Biogen
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply...
Biogen
@biogen
Mar 23, 2015
Embracing our future and our past #Biogen
Biogen
@biogen
Oct 22, 2019
Today Biogen is proud to announce an update on aducanumab, our investigational drug for early Alzheimer’s disease ow.ly/rFPp50wR3Cd #Alzheimers
Biogen
@biogen
May 25, 2020
“Time for action. Predict. Prevent. Repair” we couldn’t agree more with @EANeurology’s theme for #EAN2020 this year. Bernd Kieseier, MD, explains why. ow.ly/s9DS50zOph6
Biogen
@biogen
May 23, 2020
Join us at #EAN2020 when we talk about early stages of #Alzheimers, when symptoms may become visible and could potentially be detected and or diagnosed. We look forward to discussing research in diagnosing early AD #EANVirtual ow.ly/poZI50zOp3S
Biogen
@biogen
Sep 2, 2020
Following her #multiplesclerosis diagnosis, Donna felt scared and confused. Her #connections with friends and family were invaluable. #MSBeyondWords
00:00
Biogen
@biogen
Sep 13, 2019
Malin had to overcome many challenges when she was diagnosed with #MultipleSclerosis. With support from her family, she learned to live with #MS and support others. #MSBeyondWords #ECTRIMS2019
00:00
Biogen
@biogen
Mar 23, 2016
Biogen opposes #NCGA attempt to undermine equality in NC via #HB2. We support advancing the power of difference bit.ly/1OUt95u
Biogen
@biogen
Sep 8, 2020
“I think the most important connection was probably my mother.” Watch Samira discuss the #connections she made during her #MS journey. #MSBeyondWords #multiplesclerosis #ECTRIMS2020
00:00
Biogen
@biogen
Jul 8, 2020
Today, Biogen completed submission of a BLA filing to @US_FDA for review of our investigational drug for #Alzheimer’s disease. If approved, this would be the first drug with potential to meaningfully change the course of Alzheimer’s disease.
FDA Submission for Alzheimer’s Disease Treatment
From investors.biogen.com